Graphique du cours de l'action SCNI
SCNI Dividendes
Scinai Immunotherapeutics Ltd
$0.25
-0.07%
$0
À la fermeture : Aug 05, 16:00:00 GMT-4
$0.22
-8.12%
$-0.02
Pré-Marché: Aug 06, 08:20:14 GMT-4
Retour
Scinai Immunotherapeutics Ltd (SCNI) Dividendes
Statistiques clés
Clôture préc.
$0.2502
Prix d'ouverture
$0.25
Plage de la journée
$0.2297 - $0.25
Plage de 52 semaines
$0.2147 - $3.48
Volume
305.7K
Volume moyen
2.5M
Rendement en dividend
--
BPA (TTM)
-0.00
Capitalisation boursière
$1.1M
Qu’est-ce que SCNI ?
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
Fonctionnalités
© 2026 Edgen fonctionné par
